USD 12.39
(-4.18%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 159.4 Million USD | -38.93% |
2022 | 261 Million USD | 51.04% |
2021 | 172.8 Million USD | -25.93% |
2020 | 233.3 Million USD | -24.91% |
2019 | 310.7 Million USD | 25.43% |
2018 | 247.7 Million USD | -54.22% |
2017 | 541.1 Million USD | -6.55% |
2016 | 579 Million USD | 0.16% |
2015 | 578.1 Million USD | -8.57% |
2014 | 632.3 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 164.9 Million USD | -1.38% |
2024 Q1 | 167.2 Million USD | 4.89% |
2024 Q3 | 152.6 Million USD | -7.46% |
2023 Q3 | 287.8 Million USD | 22.89% |
2023 Q4 | 159.4 Million USD | -44.61% |
2023 FY | 159.4 Million USD | -38.93% |
2023 Q1 | 237.1 Million USD | -9.16% |
2023 Q2 | 234.2 Million USD | -1.22% |
2022 Q3 | 284.6 Million USD | -1.08% |
2022 Q2 | 287.7 Million USD | -2.28% |
2022 Q1 | 294.4 Million USD | 70.37% |
2022 FY | 261 Million USD | 51.04% |
2022 Q4 | 261 Million USD | -8.29% |
2021 FY | 172.8 Million USD | -25.93% |
2021 Q2 | 212.5 Million USD | -5.6% |
2021 Q1 | 225.1 Million USD | -3.51% |
2021 Q3 | 191.1 Million USD | -10.07% |
2021 Q4 | 172.8 Million USD | -9.58% |
2020 Q3 | 304.6 Million USD | -0.88% |
2020 Q4 | 233.3 Million USD | -23.41% |
2020 Q1 | 307 Million USD | -1.19% |
2020 FY | 233.3 Million USD | -24.91% |
2020 Q2 | 307.3 Million USD | 0.1% |
2019 Q2 | 313.3 Million USD | 2.52% |
2019 FY | 310.7 Million USD | 25.43% |
2019 Q4 | 310.7 Million USD | 0.1% |
2019 Q3 | 310.4 Million USD | -0.93% |
2019 Q1 | 305.6 Million USD | 23.38% |
2018 Q2 | 247.4 Million USD | -54.35% |
2018 Q3 | 247.6 Million USD | 0.08% |
2018 Q4 | 247.7 Million USD | 0.04% |
2018 Q1 | 542 Million USD | 0.17% |
2018 FY | 247.7 Million USD | -54.22% |
2017 Q2 | 579.9 Million USD | 0.09% |
2017 Q1 | 579.4 Million USD | 0.07% |
2017 Q3 | 580.4 Million USD | 0.09% |
2017 Q4 | 541.1 Million USD | -6.77% |
2017 FY | 541.1 Million USD | -6.55% |
2016 Q4 | 579 Million USD | -1.76% |
2016 Q3 | 589.4 Million USD | -5.54% |
2016 Q2 | 624 Million USD | 7.87% |
2016 Q1 | 578.5 Million USD | 0.07% |
2016 FY | 579 Million USD | 0.16% |
2015 Q3 | 585.9 Million USD | 0.02% |
2015 FY | 578.1 Million USD | -8.57% |
2015 Q2 | 585.8 Million USD | -7.22% |
2015 Q1 | 631.4 Million USD | -0.14% |
2015 Q4 | 578.1 Million USD | -1.33% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | 632.3 Million USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | 632.3 Million USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 98.828% |
Allurion Technologies Inc. | 2.3 Million USD | -6812.402% |
Artivion, Inc. | 305.53 Million USD | 47.829% |
Butterfly Network, Inc. | 22.83 Million USD | -598.051% |
Butterfly Network, Inc. | 22.83 Million USD | -598.051% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 86.599% |
Boston Scientific Corporation | 8.96 Billion USD | 98.221% |
CONMED Corporation | 971.48 Million USD | 83.592% |
Edwards Lifesciences Corporation | 670 Million USD | 76.209% |
Paragon 28, Inc. | 109.79 Million USD | -45.174% |
Glaukos Corporation | 383.73 Million USD | 58.461% |
Globus Medical, Inc. | 417.4 Million USD | 61.811% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -541.552% |
Integer Holdings Corporation | 959.92 Million USD | 83.395% |
Medtronic plc | 23.87 Billion USD | 99.332% |
Myomo, Inc. | 115.16 Thousand USD | -138316.117% |
Nevro Corp. | 211.47 Million USD | 24.623% |
Owlet, Inc. | 22 Thousand USD | -724445.455% |
Penumbra, Inc. | 220.9 Million USD | 27.844% |
Vicarious Surgical Inc. | 13.78 Million USD | -1056.329% |
Smith & Nephew plc | 2.17 Billion USD | 92.671% |
Sonendo, Inc. | 14.03 Million USD | -1035.732% |
STERIS plc | 3.12 Billion USD | 94.891% |
Stryker Corporation | 10.9 Billion USD | 98.538% |
Vapotherm, Inc. | 109.97 Million USD | -44.938% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 96.725% |